General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

RecruitingOBSERVATIONAL
Enrollment

33,000

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions
Type 1 DiabetesCeliac Disease
Interventions
DIAGNOSTIC_TEST

Sera and whole blood sampling

"* Study Entry: Single Nucleotide Polymorphism (SNP)-Based Genetic Risk Score at study entry.~* 2 years old: T1D autoantibodies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies~* 5 years old: T1D and celiac autoantibodies~* 9-16 year old: one-time T1D and celiac autoantibodies~* Siblings of people with T1D autoimmunity, ages 6-17 years: one-time T1D and celiac autoantibodies"

DIAGNOSTIC_TEST

Differential Gene Expression (DGE)

Opt-in: Differential Gene Expression from cord blood at birth and peripheral blood at 12 months of age

Trial Locations (4)

56601

RECRUITING

Sanford Bemidji Region Clinics, Bemidji

57105

RECRUITING

Sanford Sioux Falls Region Clinics, Sioux Falls

58112

RECRUITING

Sanford Fargo Region Clinics, Fargo

58501

RECRUITING

Sanford Bismarck Region Clinics, Bismarck

Sponsors
All Listed Sponsors
collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

collaborator

Pacific Northwest Research Institute

OTHER

collaborator

University of Exeter

OTHER

lead

Sanford Health

OTHER